UK scientists trial instant immunity antibody drug treatment for COVID-19

The study recruited the first participant in the world to the study earlier this month and has recruited 10 participants since then

Scientists in the UK have begun trials of innovative antibody drug treatments that they hope could provide instant protection against COVID-19.

The University College London Hospitals NHS Trust (UCLH) said that the researchers in the Storm Chase study believe a Long Acting AntiBody (LAAB) known as AZD7442, developed by AstraZeneca, may offer immediate and long-term protection to people who have been recently exposed to the SARS-CoV-2 coronavirus and prevent them developing COVID-19.

The study, led by UCLH virologist Dr Catherine Houlihan, recruited the first participant in the world to the study earlier this month and has recruited 10 participants since then.

“We know that this antibody combination can neutralise the virus, so we hope to find that giving this treatment via injection can lead to immediate protection against the development of COVID-19 in people who have been exposed – when it would be too late to offer a vaccine," said Houlihan.

UCLH said its new vaccine research centre is running two clinical trials testing a LAAB combination treatment to protect against COVID-19.

Not taking bets on the longevity of principles living and the security of the process not being leaked in under a month.

Expect any buildings and storage facilities related to this drug to have sudden unknown accidental damage or localized destruction.

Expect the raw material supplies to vanish off the market.

Why am I so jaded, when they blew the guts out of the #2 HCQ maker on the planet, including it’s raw materials storage, they were the global storage center if you remember, this is why.

Heard anything more about that “accident” nopes has been black holes.

The top two antiviral Pharmas are NOT going to loose their strangle hold on the planet for generations.

Logic and past events give us pretty accurate abilities to forecast what the NWO repeatedly do to remain in power.

Your welcome 😎

simply another pair of monoclonal antibodies

Sure, nothing to it. Hold on while I'll go cook up another salad of MABs in my kitchen...

AZ claims a proprietary long-acting antibody (LAAB) combination with half-life extension technology to increase the durability of the therapy for six to 12 months following a single administration. The combination of two LAABs is also designed to reduce the risk of resistance developed by the SARS-CoV-2 virus. They are in trials to evaluate the LAAB combination in different settings from prophylaxis, to outpatient treatment to hospitalization. A LAAB combination could be complementary to vaccines as a prophylactic agent, e.g. for people for whom a vaccine may not be appropriate.

AZD7442 is a combination of two LAABs derived from convalescent patients after SARS-CoV-2 infection. Discovered by Vanderbilt University Medical Center and licensed to AstraZeneca in June 2020, the LAABs were optimized by AstraZeneca with half-life extension and reduced Fc receptor binding. The half-life extended LAABs should afford six to 12 months of protection from COVID-19.2-5 The reduced Fc receptor binding aims to minimise the risk of antibody-dependent enhancement of disease - a phenomenon in which virus-specific antibodies promote, rather than inhibit, infection and/or disease.

Here's the paper by the Vanderbilt scientists: Potently neutralizing and protective human antibodies against SARS-CoV-2, 15 July 2020.

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.